Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Healthcare Medical Devices
Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real... see more

Recent & Breaking News (TSXV:ADK)

DIAGNOS Announces Closing of Oversubscribed $2.1 Million Private Placement

GlobeNewswire March 9, 2020

DIAGNOS Announces Private Placement of Common Shares

GlobeNewswire February 24, 2020

DIAGNOS Announces Shares for Debt Transaction

GlobeNewswire February 14, 2020

DIAGNOS Announces Closing of Private Placement

GlobeNewswire February 11, 2020

DIAGNOS Announces Private Placement of Common Shares

GlobeNewswire February 5, 2020

DIAGNOS Successfully Completes ISO 13485 / MDSAP Surveillance Audit

GlobeNewswire January 14, 2020

DIAGNOS AI based clinical Eye Test for Diabetic Retinopathy Demonstrates Exceptional Performance at the CHUM, expands for an Additional Six Months

GlobeNewswire January 7, 2020

DIAGNOS Announces a New Strategic Partnership Agreement in Costa Rica

GlobeNewswire December 12, 2019

DIAGNOS Announces Collaborative Agreement in the North American Borderplex Region

GlobeNewswire December 10, 2019

DIAGNOS Welcomes Mr. Francis Bellido to its Board of Directors

GlobeNewswire November 28, 2019

DIAGNOS Announces Short Term Financing

GlobeNewswire November 26, 2019

DIAGNOS and its Local Partner Selected Following a Competitive Bid from the Mexican Government

GlobeNewswire October 29, 2019

DIAGNOS Appoints New Chairman of the Board of Directors

GlobeNewswire September 25, 2019

DIAGNOS Announces Voting Results of Annual Meeting of Shareholders

GlobeNewswire September 20, 2019

DIAGNOS Announces Closing of a Private Placement

GlobeNewswire September 16, 2019

DIAGNOS Announces Private Placement

GlobeNewswire September 13, 2019

DIAGNOS Receives Medical Device Marketing Authorization from the Saudi Food and Drug Authority to commercialize CARA in Saudi Arabia

GlobeNewswire September 10, 2019

DIAGNOS Announces an Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM

GlobeNewswire September 3, 2019

DIAGNOS Announces an Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM

GlobeNewswire June 20, 2019

DIAGNOS Welcomes Mr. François Côté to its Board of Directors

GlobeNewswire June 18, 2019